See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $10.2B | n/a | n/a | |
| $8.6B | 7.1x | 20.5x | |
| $1.7B | 8.5x | -27.3x | |
| $1.5B | 5.7x | -10.7x | |
| $919M | n/a | n/a | |
| $186M | 10.1x | 13.2x | |
| $185M | 2465.0x | -5.4x | |
| $174M | n/a | n/a | |
| $46.3M | 2.7x | 13.8x | |
| $33.2M | 13.2x | -8.2x | |
| $20.0M | 15.3x | -9.0x | |
| $19.7M | n/a | n/a | |
| $6.3M | n/a | n/a | |
| -$6.0M | n/a | 0.1x | |
| -$22.4M | -0.8x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics